HOST-EXAM trial, a landmark study recently released at the ACC 2026. The trial sought to determine the effectiveness of ...

Repatha is the Only PCSK9 Inhibitor to Significantly Reduce the Risk of First CV Events in High-Risk Primary Prevention VESALIUS-CV Subgroup Findings Reinforce Benefit of Earlier Initiation of Repatha ...

Sentiment around BDCs has rebounded recently, although stock prices continue to reflect questions about reported NAVs, while ...

TM maintains industry-leading operating margins and resilient revenue growth but faces tariff impacts and geopolitical risks.

In one of the largest studies of its kind, a trial of Boston Scientific’s small, permanent cardiac implant showed that it could potentially serve as an alternative to long-term blood thinners among ...

Women taking antiseizure medication for epilepsy have around a 45% reduced risk of major congenital anomalies in their ...

SAGINAW, MI — A Saginaw woman accused of keeping her sister-in-law captive in her basement for years wants to be released ...

Lilly plans to file Foundayo with the FDA for type 2 diabetes by end of Q2 after the ACHIEVE-4 trial met its primary ...

KPMG is shrinking audit partners to cut costs and boost productivity, which usually pressures pricing and margins across the ...

Occidental Petroleum stock has pulled back sharply from recent highs, but the underlying business is stronger than the dip ...

Pharmacologic data highlight durable GI microbiome modulation, with improvement in epithelial barrier integrity, following SER-155 administration ...

We underscore the importance of upholding a rules-based international system, grounded in respect for national sovereignty and the principles of the UN Charter. In view of the profound human and ...